If you would like to know more about (young-onset) dementia and Alzheimer's disease, please visit the information page of the Flemish Alzheimer League (in Dutch) or the French-speaking Alzheimer League (in French) or visit the page dedicated to young-onset dementia (in Dutch). These platforms provide general information about the disease and offer support to people with dementia, their loved ones and informal caregivers.
Do you feel the need to talk to someone, are you looking for information or do you have questions? You can call the dementia line free of charge and anonymously on the number 0800 15 225. This service is available 24/7 for anyone who has to deal with dementia as a loved one, informal caregiver, professional, ...
1. Key messages
- In 2023, 1.4% of the Belgian population reported to suffer from Alzheimer's disease, dementia or other serious memory problems.
- Alzheimer's disease, dementia or other serious memory problems are more common in women and people with a lower-educated profile.
- The use of antidementia in the Flemish Region is higher compared to the Walloon Region and the Brussels-Capital Region. The use of antidementia has reduced drastically in recent years, in contrast to the percentage of people living with dementia, which is increasing over the years.
2. Percentage of dementia in Belgium
In 2023, 1.4% of the Belgian population aged over 15 suffered from Alzheimer's disease, dementia or other serious memory problems
The number of people with dementia increases with age, ranging from 0.2% in the age group 35-44 years and 45-54 years to 7.8% in the 75+ age group. Young-onset dementia is an umbrella term that encompasses various forms of dementia in which the first symptoms occur before the age of 65. Based on this definition, the percentage of dementia and severe memory problems at a young age is estimated to be 0.3%.
More women than men suffer from Alzheimer's disease, dementia and other serious memory problems, namely 1.2% of men compared to 1.6% of women. Especially in the higher age groups, the difference in percentage between men and women is clearly visible. The higher life expectancy among women seems to be the biggest explanatory factor for this [1].
Source: Health Interview Survey (HIS) [2]
The level of education is associated with the occurrence of Alzheimer's disease, dementia, and other serious memory problems
After standardization for age, there are respectively 2.9 times and 3.2 times more individuals with dementia with a low level of education (no diploma or diploma of primary education) compared to individuals with a moderate (diploma of secondary education) or highly educated (diploma of higher education) profile.
This can be explained by the so-called 'cognitive reserve' that is present to a greater extent in people with a higher educated profile. Education and the opportunity for lifelong mental stimulation have a delaying effect on the presentation of the first symptoms of dementia [3].
Source: Health Interview Survey (HIS) [2]
The number of users of reimbursed anti-dementia medication decreased in the three regions in the period from 2012 to 2020
However, the decreasing trend in the use of reimbursed anti-dementia, more specifically Memantine and Anticholinesterases, does not reflect a decrease in the number of people with dementia in recent years. The decrease is mainly due to a change in reimbursement as a result of the limited proven effects of this medication in dementia [4].
In terms of regional disparity, the number of users is highest in the Flemish Region, followed by the Walloon Region and the Brussels-Capital Region. These regional differences have remained stable over the years.
Source: Permanent Sample (EPS) by the Intermutualistic Agency (IMA) [5]
Dementia is more common in people with an increased reimbursement status
The number of anti-dementia users with an increased reimbursement status is almost twice as high compared to users with a standard reimbursement. Between 2012 and 2020, however, the difference between the two groups narrowed.
Source: Permanent Sample (EPS) by the Intermutualistic Agency (IMA) [5]
3. Percentage of dementia in Europe
The estimated number of individuals with Alzheimer's disease and dementia in Belgium is lower than the average of the EU-14 countries
According to Alzheimer Europe, an estimated 1.9% of the population in Belgium lives with dementia, compared to an average of 2.0% in the EU-14 countries [6].
Source: Alzheimer Europe [6]
4. Dementia mortality
Mortality due to Alzheimer's disease and other forms of dementia is higher in women than in men
In 2022, 48 and 55 per 100,000 men and women died, respectively, as a result of Alzheimer's disease or other forms of dementia. These differences seem to be mainly due to the higher proportion of women in older age groups compared to men.
Source: Statbel [7]
5. Read more
View the metadata for this indicator
Background
Dementia is a collective term for over sixty syndromes that affect memory, thinking and functioning in daily life. Dementia is often progressive, which means that the disease often has a gradual onset and that the symptoms worsen over time [8, 9].
The most common form of dementia is Alzheimer's disease, estimated to account for 60-70% of all dementias. Other common forms include frontotemporal dementia, Lewy body dementia, and vascular dementia. The underlying disease process is different for each, but leads in every one of them to a similar clinical picture with its own nuances. For example, frontotemporal dementia is characterized by changes in personality and behaviour, with Lewy body dementia hallucinations and motor problems appearing to be more prominent. Each form of dementia therefore has its own unique characteristics and challenges, and these can also greatly vary from person to person and require a tailor-made and personal approach [8, 9].
There is no curative treatment available for dementia. There are symptomatic treatments that have no effect on the underlying disease process, but are able to stabilize the symptoms. In addition to medication-based symptomatic treatments, there are also other conservative therapies, such as cognitive rehabilitation in memory clinics, which are often aimed at supporting the patient and his environment [9].
Age is the main risk factor of dementia. Having other chronic conditions, such as diabetes, cardiovascular disease and Parkinson's disease, among others, can also lead to an increased risk of developing dementia. In a limited number of cases, a genetic component can be identified, but usually genetics do not play a role [8, 9].
As there is no national dementia registry, indicators from the Health Interview Survey (HIS) and the Permanent Sample (EPS), as well as the Alzheimer Europe prediction model, were used:
- The HIS is a self-reported annual health survey. Among other things, the presence of some chronic conditions in the past 12 months is questioned. Alzheimer's disease, dementia and other serious memory problems are grouped together in one category in the survey. The HIS is based on a sample from the total population and allows representative estimates to be made of certain subgroups based on, for example, age, sex, etc. For Alzheimer's disease and other forms of dementia, only persons older than 15 years are taken into account.
- The Intermutualistic Agency (IMA) collects health data from the Belgian population affiliated to the compulsory health insurance through its Permanent Sample (EPS). The prevalence of Alzheimer's disease is estimated on the basis of the number of insured persons with a supply of antidementia (ATC N06D; more specifically memantine N06DDX01 and anticholinesterases N06DA). The reimbursed use of antidementia was thus used as a proxy for Alzheimer's disease and other forms of dementia.
-
The comparison between the European countries is based on estimates of the number of people with dementia based on age and gender as determined in the Alzheimer Europe prediction model.
The difference in figures can be explained by the use of different data sources (health registers vs. estimates) and the definitions used to identify people with dementia.
Definitions
- Referential reimbursement status
- People with a low income are entitled to a preferential allowance. They pay less for health care and have other financial benefits. Currently, this is the only variable available in the IMA-AIM atlas that can be used to assess socio-economic differences.
- EU-14
- The EU-14 includes all countries that were part of the European Union between 1995 and 2022, with the exception of the United Kingdom, which is no longer part of the European Union (i.e. Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, the Netherlands, Portugal, Spain and Sweden). The comparison of the health status in Belgium is made with the EU-14, and not with the EU-28, because this historical group shows more socio-economic similarities than the EU-28.
- Age-standardized mortality rate
- The age-standardization is a weighted average of age-specific mortality rates to remove variations arising from differences in age structure between population groups.
References
- Alzheimer’s society, UK. https://www.alzheimers.org.uk/
- Health Interview Survey, Sciensano, 1997-2023. https://his.wiv-isp.be/
- Meng X, D'Arcy C. Education and dementia in the context of the cognitive reserve hypothesis: a systematic review with meta-analyses and qualitative analyses. PLoS One. 2012;7(6):e38268. doi: 10.1371/journal.pone.0038268. Epub 2012 Jun 4. PMID: 22675535; PMCID: PMC3366926.
- Intermutualistisch Agentschap, Antidementia in België. https://aim-ima.be/Antidementia-in-Belgie?lang=nl
- Intermutualistic Agency Atlas. http://atlas.aim-ima.be/base-de-donnees
- Alzheimer Europe, Prevalence of dementia in Europe. https://www.alzheimer-europe.org/dementia/prevalence-dementia-europe?language_content_entity=en
- Statbel, Causes of death. https://statbel.fgov.be/en/themes/population/mortality-life-expectancy-and-causes-death/causes-death
- Global action plan on the public health response to dementia 2017–2025. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO.
- Expertisecentrum Dementia Vlaanderen. https://dementie.be/
Please cite this page as: Sciensano. Dementia, 16 June 2026, Brussels, Belgium, https://www.healthybelgium.be/en/health-status/non-communicable-diseases/dementia